Certain thienopyrrolyl and furanopyrrolyl compounds are disclosed as useful to treat or prevent disorders and conditions mediated by the histamine H.sub.4 receptor, including allergic rhinitis.

 
Web www.patentalert.com

> Vascular endothelial growth factor 2

~ 00351